Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
plasma neurofilament light for early differentiation of multiple system atrophy from parkinson disease
Original title: “Plasma neurofilament light for early differentiation of multiple system atrophy from Parkinson disease.”
multiple system atrophy
Original title: “[Multiple system atrophy].”
magnetic resonance imaging markers predict disease progression in early stage multiple system atrophy a 2 year prospective cohort study
Original title: “Magnetic resonance imaging markers predict disease progression in early-stage multiple system atrophy: a 2-year prospective cohort study.”
pre diagnostic factors associated with coding based incident multiple system atrophy a nested case control study of the uk biobank
Original title: “Pre-Diagnostic Factors Associated with Coding-Based Incident Multiple System Atrophy: A Nested Case-Control Study of the UK Biobank.”
multiple system atrophy cure and care
Original title: “Multiple system atrophy: cure and care.”
substantia nigra susceptibility to volume ratio derived from qsm as a marker for discrimination of progressive supranuclear palsy from parkinson s disease and multiple system atrophy
Original title: “Substantia Nigra Susceptibility-To-Volume Ratio Derived From QSM as a Marker for Discrimination of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy.”
single nucleus brain transcriptomics reveals microglia dysfunction in multiple system atrophy
Original title: “Single-nucleus brain transcriptomics reveals microglia dysfunction in multiple system atrophy.”
Phase 3 Mascot study reaches key milestone for potential first-in-class therapy
Original title: “Lundbeck completes patient randomisation early in global MSA trial”